Figure 2
Effect of ulinastatin on lymphocyte subsets and IL-6. Ulinastatin (U) administration significantly increased the rate of CD3+ (A) and CD4+ (B) cells, and ratio of CD4+/CD8+ (D), but decreased the rate of CD8+ (C) cells and release of IL-6 (E) compared to control group (C) on postoperative days 1 (D1) and 3 (D2; P < 0.05). D0 = 1 hour before surgery, D3 = Postoperative day 7.